OP038 NUTRITIONAL STATUS AND QUALITY OF LIFE IN OUTPATIENTS WITH SYSTEMIC IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS (AL) AT DIAGNOSIS

2010 ◽  
Vol 5 (2) ◽  
pp. 16 ◽  
Author(s):  
R. Caccialanza ◽  
G. Palladini ◽  
C. Klersy ◽  
C. Bonardi ◽  
B. Cameletti ◽  
...  
2006 ◽  
Vol 83 (2) ◽  
pp. 350-354 ◽  
Author(s):  
Riccardo Caccialanza ◽  
Giovanni Palladini ◽  
Catherine Klersy ◽  
Hellas Cena ◽  
Christina Vagia ◽  
...  

2021 ◽  
Author(s):  
Shana Souza Grigoletti ◽  
Priccila Zuchinali ◽  
Emilie Lemieux-Blanchard ◽  
Stephanie Bechard ◽  
Bernard Lemieux ◽  
...  

Background: Immunoglobulin light chain (AL) amyloidosis is a complex disease marked by a poor clinical portrait and prognosis generally leading to organ dysfunction and shortened survival. We aimed to review the available evidence on whether AL amyloidosis can lead to malnutrition, thus having a negative impact on quality of life (QoL) and survival. Materials: We searched Pubmed with no restrictions to the year of publication or language. Retrospective or prospective, observational, and interventional studies that reported data regarding AL amyloidosis and nutritional status were included. Results: From 62 articles retrieved, 23 were included. Malnutrition was prevalent in up to 65% of patients with AL Amyloidosis. Prevalence of weight loss of 10% or more ranged from 6 to 22% of patients, while a body mass index of < 22 kg/m2 was found in 22 to 42%. Weight loss, lower BMI and other indicators of poor nutritional status were negatively associated with quality of life and survival. Only one RCT focused on nutritional counselling was found and reported positive results on patients' QoL and survival. Conclusion Despite inconsistencies across assessment criteria, the available data reveal that weight loss and malnutrition are common features in patients with AL amyloidosis. This review reinforces the premise that an impaired nutritional status can be negatively associated with QoL and survival in patients with AL amyloidosis, and therefore should be further investigated.


Author(s):  
Shana Souza Grigoletti ◽  
Priccila Zuchinali ◽  
Émilie Lemieux-Blanchard ◽  
Stéphanie Béchard ◽  
Bernard Lemieux ◽  
...  

2011 ◽  
Vol 91 (3) ◽  
pp. 399-406 ◽  
Author(s):  
Riccardo Caccialanza ◽  
Giovanni Palladini ◽  
Catherine Klersy ◽  
Emanuele Cereda ◽  
Chiara Bonardi ◽  
...  

Haematologica ◽  
2012 ◽  
Vol 98 (1) ◽  
pp. 136-140 ◽  
Author(s):  
P. T. Sattianayagam ◽  
T. Lane ◽  
Z. Fox ◽  
A. Petrie ◽  
S. D. J. Gibbs ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Linchun Xu ◽  
Yongzhong Su

AbstractImmunoglobulin light chain amyloidosis (AL) is an indolent plasma cell disorder characterized by free immunoglobulin light chain (FLC) misfolding and amyloid fibril deposition. The cytogenetic pattern of AL shows profound similarity with that of other plasma cell disorders but harbors distinct features. AL can be classified into two primary subtypes: non-hyperdiploidy and hyperdiploidy. Non-hyperdiploidy usually involves immunoglobulin heavy chain translocations, and t(11;14) is the hallmark of this disease. T(11;14) is associated with low plasma cell count but high FLC level and displays distinct response outcomes to different treatment modalities. Hyperdiploidy is associated with plasmacytosis and subclone formation, and it generally confers a neutral or inferior prognostic outcome. Other chromosome abnormalities and driver gene mutations are considered as secondary cytogenetic aberrations that occur during disease evolution. These genetic aberrations contribute to the proliferation of plasma cells, which secrete excess FLC for amyloid deposition. Other genetic factors, such as specific usage of immunoglobulin light chain germline genes and light chain somatic mutations, also play an essential role in amyloid fibril deposition in AL. This paper will propose a framework of AL classification based on genetic aberrations and discuss the amyloid formation of AL from a genetic aspect.


2017 ◽  
Vol 23 (8) ◽  
pp. S114
Author(s):  
Kristen McCausland ◽  
Spencer D. Guthrie ◽  
Tiffany Quock ◽  
Miyo Yokota ◽  
Martha Bayliss ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document